Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217204 | PMC |
http://dx.doi.org/10.1038/s41433-021-01610-1 | DOI Listing |
Am J Ophthalmol Case Rep
March 2025
Department of Ophthalmology, Asahikawa Medical University, Asahikawa, Japan.
Purpose: To describe a case of an elderly woman who presented with acute choroidal elevation, and the elevation disappeared without any treatment a month after the onset.
Observation: A 64-year-old woman presented to the clinic with complaint of blurred vision in her left eye. Her left visual acuity was 20/32 and choroidal elevation in the macular and subretinal fluid of the left eye was observed with optical coherence tomography (OCT), and no abnormalities in her right eye.
Ophthalmic Physiol Opt
January 2025
Vision and Hearing Sciences Research Centre, Anglia Ruskin University, Cambridge, UK.
Purpose: Wearable electronic low vision enhancement systems (wEVES) improve visual function but are not widely adopted by people with vision impairment. Here, qualitative research methods were used to investigate the usefulness of wEVES for people with age-related macular degeneration (AMD) after an extended home trial.
Methods: Following a 12-week non-masked randomised crossover trial, semi-structured interviews were completed with 34 participants with AMD, 64.
Clin Exp Optom
January 2025
Department of Ophthalmology, Dokuz Eylul University, Izmir, Turkey.
BMC Ophthalmol
January 2025
Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Purpose: Proliferative vitreoretinopathy (PVR) is a complication of retinal detachment which requires multiple vitreoretinal surgical interventions and frequent use of oil endotamponade. In this study, we conducted an in-depth analysis of complications associated with the use of heavy silicone oil in the management of inferior PVR.
Methods: A retrospective cohort study of 20 eyes that underwent vitrectomy for inferior PVR with use of heavy silicone oil (Densiron 68) between March 2021 and October 2022 at Oxford Eye Hospital.
Medicine (Baltimore)
January 2025
Xi'an BRIGHT Eye Hospital Group Co Ltd. Xi'an, Shaanxi, China.
Rationale: Macular damage is a rare yet significant ocular complication of coronavirus disease 2019 (COVID-19) infection. This report highlights the clinical features, diagnosis, treatment, and outcomes in 2 cases of COVID-19-associated macular damage, contributing to the understanding of its pathophysiology and management.
Patient Concerns: Both patients presented with a sudden onset of visual impairment and black shadows in their central visual fields shortly after contracting COVID-19.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!